{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:58:42Z","timestamp":1740146322709,"version":"3.37.3"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T00:00:00Z","timestamp":1524441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["521-2014-3341"],"award-info":[{"award-number":["521-2014-3341"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["150393, CAN 2014\/702"],"award-info":[{"award-number":["150393, CAN 2014\/702"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004435","name":"Association for International Cancer Research","doi-asserted-by":"publisher","award":["130086"],"award-info":[{"award-number":["130086"]}],"id":[{"id":"10.13039\/100004435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["TJ-2014-0038"],"award-info":[{"award-number":["TJ-2014-0038"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR-2014-0038"],"award-info":[{"award-number":["PR-2014-0038"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["6137-14"],"award-info":[{"award-number":["6137-14"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["538-2013-8807"],"award-info":[{"award-number":["538-2013-8807"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["621-2014-4718"],"award-info":[{"award-number":["621-2014-4718"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["150393, CAN 2015\/751"],"award-info":[{"award-number":["150393, CAN 2015\/751"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C21383"],"award-info":[{"award-number":["C21383"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A6950"],"award-info":[{"award-number":["A6950"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["182735"],"award-info":[{"award-number":["182735"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["732200"],"award-info":[{"award-number":["732200"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["911884"],"award-info":[{"award-number":["911884"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["911789"],"award-info":[{"award-number":["911789"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA95684"],"award-info":[{"award-number":["R01 CA95684"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0195956","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T17:31:31Z","timestamp":1524504691000},"page":"e0195956","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-0169","authenticated-orcid":true,"given":"Marcus J. G. W.","family":"Ladds","sequence":"first","affiliation":[]},{"given":"Andr\u00e9s","family":"Pastor-Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"given":"Gergana","family":"Popova","sequence":"additional","affiliation":[]},{"given":"Ingeborg M. M.","family":"van Leeuwen","sequence":"additional","affiliation":[]},{"given":"Kai Er","family":"Eng","sequence":"additional","affiliation":[]},{"given":"Catherine J.","family":"Drummond","sequence":"additional","affiliation":[]},{"given":"Lars","family":"Johansson","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Svensson","sequence":"additional","affiliation":[]},{"given":"Nicholas J.","family":"Westwood","sequence":"additional","affiliation":[]},{"given":"Anna R.","family":"McCarthy","sequence":"additional","affiliation":[]},{"given":"Fredrik","family":"Tholander","sequence":"additional","affiliation":[]},{"given":"Mihaela","family":"Popa","sequence":"additional","affiliation":[]},{"given":"David P.","family":"Lane","sequence":"additional","affiliation":[]},{"given":"Emmet","family":"McCormack","sequence":"additional","affiliation":[]},{"given":"Gerald M.","family":"McInerney","sequence":"additional","affiliation":[]},{"given":"Ravi","family":"Bhatia","sequence":"additional","affiliation":[]},{"given":"Sonia","family":"La\u00edn","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2018,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ccr.2008.03.004","article-title":"Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator","volume":"13","author":"S Lain","year":"2008","journal-title":"Cancer Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1002135","DOI":"10.1371\/journal.pgen.1002135","article-title":"SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability","volume":"7","author":"GM Marshall","year":"2011","journal-title":"PLoS Genetics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1073\/pnas.1105304109","article-title":"The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop","volume":"109","author":"A Menssen","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"L Li","year":"2012","journal-title":"Cancer Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2012.83","article-title":"SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells","volume":"32","author":"Z Wang","year":"2013","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V122.21.2685.2685","article-title":"Pharmacological Inhibition Of The SIRT1 Deacetylase With The Small Molecule Inhibitor Tenovin-6 Enhances Ablation Of FLT3-ITD+ LSC In Combination With TKI Treatment","volume":"122","author":"T Osdal","year":"2013","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","article-title":"SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells","volume":"15","author":"L Li","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","article-title":"Negative control of p53 by Sir2alpha promotes cell survival under stress","volume":"107","author":"J Luo","year":"2001","journal-title":"Cell"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"H Vaziri","year":"2001","journal-title":"Cell"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"RL Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1158\/0008-5472.CAN-10-0646","article-title":"RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models","volume":"70","author":"H Yang","year":"2010","journal-title":"Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"H Davies","year":"2002","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2165\/11640870-000000000-00000","article-title":"Vemurafenib: targeted inhibition of mutated BRAF for treatment of advanced melanoma and its potential in other malignancies","volume":"72","author":"A Sharma","year":"2012","journal-title":"Drugs"},{"key":"ref14","first-page":"243","article-title":"Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma","volume":"4","author":"R Fisher","year":"2012","journal-title":"Cancer Manag Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMc1302338","article-title":"Hepatotoxicity with Combination of Vemurafenib and Ipilimumab","volume":"368","author":"A Ribas","year":"2013","journal-title":"New England Journal of Medicine"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1158\/2326-6066.CIR-13-0092","article-title":"Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy","volume":"1","author":"DB Johnson","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.2697","article-title":"Autophagy: cellular and molecular mechanisms","volume":"221","author":"D Glick","year":"2010","journal-title":"The Journal of Pathology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1101\/gad.1599207","article-title":"Autophagy: process and function","volume":"21","author":"N Mizushima","year":"2007","journal-title":"Genes Dev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","article-title":"Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies","volume":"625","author":"VR Solomon","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1074\/jbc.M110.151324","article-title":"Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis","volume":"286","author":"JS Carew","year":"2011","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"GV Helgason","year":"2011","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.clon.2011.09.010","article-title":"The role of autophagy in clinical practice","volume":"24","author":"AL Swampillai","year":"2012","journal-title":"Clin Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/cbt.11.2.14622","article-title":"Autophagy as a therapeutic target in cancer","volume":"11","author":"N Chen","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0163-7258(93)90056-J","article-title":"Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum","volume":"57","author":"AF Slater","year":"1993","journal-title":"Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00007691-198907000-00001","article-title":"Recent developments in the understanding of the pharmacokinetics and mechanism of action of chloroquine","volume":"11","author":"EO Titus","year":"1989","journal-title":"Ther Drug Monit"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1124\/dmd.109.028480","article-title":"Vacuolar ATPase-mediated cellular concentration and retention of quinacrine: a model for the distribution of lipophilic cationic drugs to autophagic vacuoles","volume":"37","author":"F Marceau","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.taap.2007.12.031","article-title":"Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: procainamide-induced autophagic cell vacuolization","volume":"228","author":"G Morissette","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1083\/jcb.85.3.839","article-title":"Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling","volume":"85","author":"A Gonzalez-Noriega","year":"1980","journal-title":"J Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/0006-291X(75)90506-9","article-title":"Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake","volume":"66","author":"UN Wiesmann","year":"1975","journal-title":"Biochem Biophys Res Commun"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e1483","DOI":"10.1038\/cddis.2014.385","article-title":"SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth","volume":"5","author":"L Ma","year":"2014","journal-title":"Cell Death Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/srep01275","article-title":"Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6","volume":"3","author":"SF Maccallum","year":"2013","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1038\/bjc.2013.601","article-title":"p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia","volume":"109","author":"MJ Groves","year":"2013","journal-title":"Br J Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e2608","DOI":"10.1038\/cddis.2017.25","article-title":"Tenovin-6 impairs autophagy by inhibiting autophagic flux","volume":"8","author":"H Yuan","year":"2017","journal-title":"Cell Death Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.bmc.2012.01.001","article-title":"Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins","volume":"20","author":"AR McCarthy","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1158\/1535-7163.MCT-12-0900","article-title":"Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent manner","volume":"12","author":"AR McCarthy","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1038\/sj.onc.1201018","article-title":"Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2","volume":"14","author":"JP Blaydes","year":"1997","journal-title":"Oncogene"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4161\/auto.6.5.12112","article-title":"A novel quantitative flow cytometry-based assay for autophagy","volume":"6","author":"KE Eng","year":"2010","journal-title":"Autophagy"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"PK Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1128\/MCB.26.1.28-38.2006","article-title":"Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage","volume":"26","author":"JM Solomon","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4161\/auto.6823","article-title":"Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62\/SQSTM1","volume":"4","author":"E Shvets","year":"2008","journal-title":"Autophagy"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Y Kabeya","year":"2000","journal-title":"EMBO J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4161\/auto.4600","article-title":"How to interpret LC3 immunoblotting","volume":"3","author":"N Mizushima","year":"2007","journal-title":"Autophagy"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/auto.19496","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy","volume":"8","author":"DJ Klionsky","year":"2012","journal-title":"Autophagy"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ncb1730","article-title":"Regulation of autophagy by cytoplasmic p53","volume":"10","author":"E Tasdemir","year":"2008","journal-title":"Nat Cell Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2006.05.034","article-title":"DRAM, a p53-induced modulator of autophagy, is critical for apoptosis","volume":"126","author":"D Crighton","year":"2006","journal-title":"Cell"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4161\/auto.1.2.1697","article-title":"Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy","volume":"1","author":"I Tanida","year":"2005","journal-title":"Autophagy"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2407-11-203","article-title":"P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation","volume":"11","author":"KA Avery-Kiejda","year":"2011","journal-title":"BMC Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","volume":"468","author":"CM Johannessen","year":"2010","journal-title":"Nature"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/157489209787002461","article-title":"Recent developments in anti-cancer agents targeting the Ras\/Raf\/ MEK\/ERK pathway","volume":"4","author":"KK Wong","year":"2009","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e49366","DOI":"10.1371\/journal.pone.0049366","article-title":"Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro","volume":"7","author":"RA Ndolo","year":"2012","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"AM Kaufmann","year":"2007","journal-title":"J Pharm Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-409X(99)00065-4","article-title":"Lysosome membrane permeability: implications for drug delivery","volume":"41","author":"JB Lloyd","year":"2000","journal-title":"Adv Drug Deliv Rev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4161\/cc.20254","article-title":"An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells","volume":"11","author":"IM van Leeuwen","year":"2012","journal-title":"Cell Cycle"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0195956","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:27:06Z","timestamp":1588969626000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0195956"}},"subtitle":[],"editor":[{"given":"Vladimir","family":"Trajkovic","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2018,4,23]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0195956","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,4,23]]}}}